Editorial Commentary


OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer

Alejandro Martin Sanchez, Armando Orlandi, Gianluca Franceschini, Flavia De Lauretis, Daniela Terribile, Antonio Franco, Riccardo Masetti

Download Citation